TLR2 and asthma: In a mouse asthma model, sublingual coadministration of an antigen and the synthetic TLR2 ligand Pam3CSK4 decreased airway hyperresponsiveness and reduced antigen-specific T helper 2 (TH2) responses in the draining cervical lymph nodes (16).